Aemetis (AMTX) Expected to Announce Earnings on Thursday

Aemetis (NASDAQ:AMTX) is expected to announce its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.28) per share and revenue of $72.07 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 12:30 PM ET.

Aemetis Stock Down 0.7%

Shares of AMTX stock opened at $1.39 on Thursday. Aemetis has a 12-month low of $1.22 and a 12-month high of $3.66. The firm has a fifty day moving average of $1.52 and a 200-day moving average of $1.94. The company has a market capitalization of $92.02 million, a price-to-earnings ratio of -0.86 and a beta of 2.61.

Hedge Funds Weigh In On Aemetis

Institutional investors have recently added to or reduced their stakes in the company. Creative Planning acquired a new stake in Aemetis in the second quarter valued at $30,000. Bank of America Corp DE lifted its stake in Aemetis by 62.6% in the 3rd quarter. Bank of America Corp DE now owns 38,526 shares of the specialty chemicals company’s stock valued at $87,000 after purchasing an additional 14,836 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Aemetis by 206.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock valued at $57,000 after purchasing an additional 15,474 shares during the last quarter. Engineers Gate Manager LP bought a new position in Aemetis during the second quarter worth about $42,000. Finally, Centiva Capital LP acquired a new position in Aemetis during the third quarter worth approximately $39,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AMTX has been the topic of several recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, January 21st. Ascendiant Capital Markets dropped their target price on Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Aemetis has an average rating of “Moderate Buy” and an average price target of $17.00.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.